Shanghai MicuRx Pharmaceutical Co., Ltd.

¥5.03As of Sun 8 Nov 2026, 12:00 UTC
SSE:688373Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR (10.24%)
Div yield —
ROE (46.96%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.49
PE TTM —
TSR TTM (33.11%)
Mkt cap ¥3.301B
ROIC (11.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.17
2.76%
(18.97%)
Hold 12|8|6|12|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.08
0.08
10.57%
6.48%
(5.68%)
(3.73%)
Revenue¥M
240.7
243.0
243.7
257.7
12.15%
7.59%
6.94%
11.19%
Peers (US$495.8M)
Cap (US$)
PE
495.8M
16.44x
499.0M
3.720x
Capital
TTM
5Y
10Y
Leveragex
0.760
—
—
EBIT/Intx
1.133
1.599
1.315
Own earn%
(165.32)
70.69
44.81
Sh yield%
51.16
26.48
26.90
Owners
Insiders/Inst%
12.41
54.16
Short interest%
2.66
SBC / revenue%
1.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
29–34
$1 testx
0.1
Incr. ROIC%
10